CompletedPhase 3

Study to Evaluate Frozen Versus Refrigerated MMRV (Combined Measles, Mumps, Rubella, and Varicella) Investigational Vaccine (V221-016)

1,200 participantsStarted 2002-09-26

Plain-language summary

The purpose of this study is to demonstrate that an investigational refrigerated vaccine with measles, mumps, rubella, and varicella is well tolerated and has similar immune response when compared to a frozen vaccine with measles, mumps, rubella, and varicella.

Who can participate

Age range12 Months – 23 Months

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Healthy children 12-23 months of age Exclusion Criteria: * Previously had measles, mumps, rubella, or varicella * Compromised immune system

What they're measuring

Percent of patients demonstrating adequate antibody titers 6 weeks following administration

Trial details

NCT IDNCT00092430

SponsorMerck Sharp & Dohme LLC

Sponsor typeINDUSTRY

Study typeINTERVENTIONAL

Primary completion2003-06-09

View on ClinicalTrials.gov More Measles trials